Contracts › 75A50119C00054
75A50119C00054: This Contract Includes Preclinical and Manufacturing Development Activities Including Cell Line Development Process Development Non-Clinical Efficacy Studies Non-Clinical Safety Studies Manufacturing Activities Clinical Activities and All As
Awarded to Biofactura Inc by Office of Assistant Secretary for Preparedness and Response.
$65.8Mobligated
$65.8Mpotential value
30 March 2029current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50119C00054 |
|---|---|
| Awardee | Biofactura Inc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN41 Health R&D Services; Health Care - Other; Basic Research |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 26 September 2019 to 30 March 2029 |
| Potential end | 30 March 2029 |
| Estimated recompete solicitation | ~Q4 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record